129 related articles for article (PubMed ID: 38282232)
1. Factors affecting cervical screening using the health belief model during the last decade: A systematic review and meta-analysis.
Al-Ani A; Hammouri M; Sultan H; Al-Huneidy L; Mansour A; Al-Hussaini M
Psychooncology; 2024 Jan; 33(1):e6275. PubMed ID: 38282232
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Preventive Behavior for Cervical Cancer with the Health Belief Model.
Shirazi Zadeh Mehraban S; Namdar A; Naghizadeh MM
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2155-2163. PubMed ID: 30139219
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional study of barriers to cervical cancer screening uptake in Ghana: An application of the health belief model.
Ampofo AG; Adumatta AD; Owusu E; Awuviry-Newton K
PLoS One; 2020; 15(4):e0231459. PubMed ID: 32352983
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
Vigneshwaran E; Goruntla N; Bommireddy BR; Mantargi MJS; Mopuri B; Thammisetty DP; Veerabhadrappa KV; Bukke SPN
BMC Cancer; 2023 Dec; 23(1):1216. PubMed ID: 38066496
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
Sumarmi S; Hsu YY; Cheng YM; Lee SH
Reprod Health; 2021 Jun; 18(1):138. PubMed ID: 34193195
[TBL] [Abstract][Full Text] [Related]
7. Barriers to Cervical Cancer Screening in Burkina Faso: Needs for Patient and Professional Education.
Compaore S; Ouedraogo CMR; Koanda S; Haynatzki G; Chamberlain RM; Soliman AS
J Cancer Educ; 2016 Dec; 31(4):760-766. PubMed ID: 26336956
[TBL] [Abstract][Full Text] [Related]
8. Predictors of cervical cancer screening practice among HIV positive women attending adult anti-retroviral treatment clinics in Bishoftu town, Ethiopia: the application of a health belief model.
Solomon K; Tamire M; Kaba M
BMC Cancer; 2019 Oct; 19(1):989. PubMed ID: 31646975
[TBL] [Abstract][Full Text] [Related]
9. Interventions targeted at women to encourage the uptake of cervical screening.
Staley H; Shiraz A; Shreeve N; Bryant A; Martin-Hirsch PP; Gajjar K
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD002834. PubMed ID: 34694000
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis.
Desta M; Getaneh T; Yeserah B; Worku Y; Eshete T; Birhanu MY; Kassa GM; Adane F; Yeshitila YG
PLoS One; 2021; 16(11):e0259339. PubMed ID: 34735507
[TBL] [Abstract][Full Text] [Related]
11. Predictors of cervical cancer screening intention of HIV-positive women in the central region of Ghana.
Ebu NI; Ogah JK
BMC Womens Health; 2018 Feb; 18(1):43. PubMed ID: 29482523
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing cervical cancer screening among pregnant women in Nairobi, Kenya.
Omondi AA; Shaw-Ridley MD; Soliman A
Afr J Reprod Health; 2022 Nov; 26(11):47-55. PubMed ID: 37585133
[TBL] [Abstract][Full Text] [Related]
13. Improving intervention design to promote cervical cancer screening among hard-to-reach women: assessing beliefs and predicting individual attendance probabilities in Bogotá, Colombia.
Barrera Ferro D; Bayer S; Brailsford S; Smith H
BMC Womens Health; 2022 Jun; 22(1):212. PubMed ID: 35672816
[TBL] [Abstract][Full Text] [Related]
14. Pap test adherence, cervical cancer perceptions, and HPV knowledge among HIV-infected women in a community health setting.
Lambert CC; Chandler R; McMillan S; Kromrey J; Johnson-Mallard V; Kurtyka D
J Assoc Nurses AIDS Care; 2015; 26(3):271-80. PubMed ID: 25769754
[TBL] [Abstract][Full Text] [Related]
15. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
Johnson NL; Head KJ; Scott SF; Zimet GD
Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
[TBL] [Abstract][Full Text] [Related]
16. Educational Interventions for Cervical Cancer Screening Behavior of Women: A Systematic Review.
Saei Ghare Naz M; Kariman N; Ebadi A; Ozgoli G; Ghasemi V; Rashidi Fakari F
Asian Pac J Cancer Prev; 2018 Apr; 19(4):875-884. PubMed ID: 29693331
[TBL] [Abstract][Full Text] [Related]
17. Education, income and occupation and their influence on the uptake of cervical cancer prevention strategies: A systematic review.
Murfin J; Irvine F; Meechan-Rogers R; Swift A
J Clin Nurs; 2020 Feb; 29(3-4):393-415. PubMed ID: 31713934
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Perceived Barriers on Self-Efficacy for HPV Preventive Behavior.
Bossard K; Song Y
Asian Pac J Cancer Prev; 2018 Apr; 19(4):983-988. PubMed ID: 29693957
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Predictor of Cervical Cancer Screening Service Uptake Among Women Aged 25 Years and Above in Sidama Zone, Southern Ethiopia, Using Health Belief Model.
Gemeda EY; Kare BB; Negera DG; Bona LG; Derese BD; Akale NB; Kebede KM; Koboto DD; Tekle AG
Cancer Control; 2020; 27(1):1073274820954460. PubMed ID: 32951445
[TBL] [Abstract][Full Text] [Related]
20. A comparison of behavioural models explaining cervical cancer screening uptake.
Dsouza JP; Broucke SVD; Pattanshetty S; Dhoore W
BMC Womens Health; 2022 Jun; 22(1):235. PubMed ID: 35710374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
